IMAX CCO exercises options, sells 6,188 shares at $34.2452

IMAX Chief Commercial Officer Giovanni M. Dolci reported an option exercise and same‑day sale.

Rhea-AI Filing Summary

IMAX Chief Commercial Officer Giovanni M. Dolci reported an option exercise and same‑day sale. On 11/10/2025, he exercised 6,188 stock options at $22.49 and sold 6,188 common shares at a weighted average price of $34.2452, leaving 33,000 common shares held directly.

The options were issued in 2019 and are set to expire on March 7, 2026. The filing notes remaining restricted share units of 21,574 following these transactions.

Insider Trade Summary

Exercise and Sale: 6,188 shares ($73K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Dolci Giovanni M.

Role Chief Commercial Officer & EVP

Sold 6,188 shs ($212K)

Approx. gross sale proceeds $212K

Approx. exercise cost $139K

Approx. pre-tax spread $73K

Type	Security	Shares	Price	Value
Conversion	stock options (to buy)	6,188	$22.49	$139K
Conversion	common shares	6,188	$22.49	$139K
Sale	common shares	6,188	$34.2452	$212K
holding	common shares (opening balance)	--	--	--

Holdings After Transaction: stock options (to buy) — 0 contracts (Direct); common shares — 33,000 shares (Direct); common shares (opening balance) — 33,000 shares (Direct)

Footnotes (4)

1. F1. Represents the conversion upon exercise of stock options into common shares.
2. F2. These options were issued in 2019 and are set to expire on March 7, 2026.
3. F3. The stock options became exercisable in four installments:1,237 on March 7, 2020, 1,547 on each of March 7, 2021 and March 7, 2022 and 1,857 on March 7, 2023.,
4. F4. Mr. Dolci's aggregate remaining restricted share unit and common share balances following these transactions will be 21,574 and 33,000 respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IMAX (IMAX) report?

Giovanni M. Dolci exercised 6,188 options at $22.49 and sold 6,188 shares at $34.2452 on 11/10/2025.

How many IMAX shares does Giovanni M. Dolci own after the trade?

He directly owns 33,000 common shares following the reported transactions.

What was the exercise price and sale price in the IMAX Form 4?

The exercise price was $22.49 per share; the sale price was a weighted average of $34.2452 per share.

When do the exercised IMAX options expire?

The options were issued in 2019 and are set to expire on March 7, 2026.

What restricted share unit balance remains for the IMAX executive?

The filing notes remaining restricted share units totaling 21,574 after the transactions.

What was the transaction code for the IMAX insider’s activity?

The option exercise was coded C and the share sale was coded S.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/10/2025 - 04:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dolci Giovanni M.

(Last) (First) (Middle)

7 STRATFORD PLACE

(Street)

LONDON X0 W1C 1AY

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer & EVP

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								33,000	D
common shares	11/10/2025		C		6,188(1)	A	$22.49	39,188	D
common shares	11/10/2025		S		6,188(1)	D	$34.2452	33,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock options (to buy)(2)	$22.49	11/10/2025		C			6,188	(3)	03/07/2026	common shares	6,188	$22.49	0(4)	D

Explanation of Responses:

1. Represents the conversion upon exercise of stock options into common shares.

2. These options were issued in 2019 and are set to expire on March 7, 2026.

3. The stock options became exercisable in four installments:1,237 on March 7, 2020, 1,547 on each of March 7, 2021 and March 7, 2022 and 1,857 on March 7, 2023.,

4. Mr. Dolci's aggregate remaining restricted share unit and common share balances following these transactions will be 21,574 and 33,000 respectively.

Remarks:

	/s/ Kenneth I. Weissman (attorney-in-fact for Giovanni M. Dolci)	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.